Chemoenzymatic site-selective attachment to antibodies: using glycosylation sites to post-translationally program function

Chemoenzymatic site-selective attachment to antibodies: using glycosylation sites to post-translationally program function

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Khan, MA
مؤلفون آخرون:	Davis, B
التنسيق:	أطروحة
اللغة:	English
منشور في:	2021
الموضوعات:	Chemical biology Antibody Glycobiology Chemistry Bispecific antibodies

مواد مشابهة

The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites
حسب: Elizabeth A. Lampros, وآخرون
منشور في: (2022-01-01)

Investigations into novel enzymatic glycosylation methods
حسب: Taylor, T
منشور في: (2015)

Bispecific antibodies: design, therapy, perspectives
حسب: Sedykh SE, وآخرون
منشور في: (2018-01-01)

Investigating the N-linked glycan specificity of bacterial endo-beta-N-acetylglucosaminidase S
حسب: Goodfellow, J, وآخرون
منشور في: (2011)

Labeling glycans on living cells by a chemoenzymatic glycoengineering approach
حسب: Ruben T. Almaraz, وآخرون
منشور في: (2017-06-01)

Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma
حسب: Suheil Albert Atallah-Yunes, وآخرون
منشور في: (2022-01-01)

Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
حسب: Gihoon You, وآخرون
منشور في: (2021-07-01)

Role of antibody-based therapy in indolent non-Hodgkin's lymphoma
حسب: Patrick Willard, وآخرون
منشور في: (2021-01-01)

Bispecific antibody drug conjugates: Making 1+1>2
حسب: Yilin Gu, وآخرون
منشور في: (2024-05-01)

Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy
حسب: Doina Atanasiu, وآخرون
منشور في: (2025-02-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
حسب: Masaud Shah, وآخرون
منشور في: (2025-01-01)

Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues
حسب: Francis M. Barnieh, وآخرون
منشور في: (2023-11-01)

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy
حسب: Pan H, وآخرون
منشور في: (2018-05-01)

Incorporation of trehalose analogues into Mycobacterium Tuberculosis: antigen 85 and probes of bacterial infection
حسب: Backus, K
منشور في: (2011)

Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase
حسب: Kevin E. Ramos, وآخرون
منشور في: (2024-07-01)

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
حسب: Ku, Zhiqiang, وآخرون
منشور في: (2023)

Construction of Novel Bispecific Single-Domain Antibodies (BiSdAbs) with Potent Antiangiogenic Activities
حسب: Xianglei Liu, وآخرون
منشور في: (2020-03-01)

Modified Therapeutic Antibodies: Improving Efficacy
حسب: Ji-Min Dai, وآخرون
منشور في: (2021-11-01)

Inhibitory superagonistic antibodies as novel therapeutics
حسب: Donat, RF
منشور في: (2023)

Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows
حسب: Caitlin Fawcett, وآخرون
منشور في: (2024-12-01)

Emerging Role of Antibody-Drug Conjugates and Bispecific Antibodies for the Treatment of Multiple Myeloma
حسب: Waqqas Tai, وآخرون
منشور في: (2022-03-01)

Corrigendum: Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats
حسب: Monica L. Fernández-Quintero, وآخرون
منشور في: (2022-02-01)

Bispecific antibodies: a novel approach for targeting prominent biomarkers
حسب: Akshita Gupta, وآخرون
منشور في: (2020-11-01)

Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies
حسب: Gabriele Antonarelli, وآخرون
منشور في: (2021-08-01)

Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer
حسب: Emilia Rabia, وآخرون
منشور في: (2023-04-01)

Bispecific antibodies for viral immunotherapy
حسب: Elisabeth K. Nyakatura, وآخرون
منشور في: (2017-04-01)

Antigenic and immunomodulatory properties of HIV-1 gp120 N-linked glycosylation
حسب: Bonomelli, C
منشور في: (2013)

One N-glycan regulates natural killer cell antibody-dependent cell-mediated cytotoxicity and modulates Fc γ receptor IIIa/CD16a structure
حسب: Paul G Kremer, وآخرون
منشور في: (2024-10-01)

Emerging Antibodies in Cancer Therapy
حسب: Yaping Sun, وآخرون
منشور في: (2023-01-01)

Editorial: Therapeutic antibody domains against cancer
حسب: Qi Zhao, وآخرون
منشور في: (2023-08-01)

Design, synthesis and biological evaluation of glycosidase inhibitors in an anti-cancer setting
حسب: Glawar, AFG
منشور في: (2013)

Producing and prospects for the use of bispecific antibodies for the treatment of cancer
حسب: S. E. Sedykh, وآخرون
منشور في: (2019-01-01)

Intein mediated high throughput screening for bispecific antibodies
حسب: Tim Hofmann, وآخرون
منشور في: (2020-01-01)

Injection site reaction to teclistamab in a patient with multiple myeloma
حسب: Isabel C. Yoon, BS, وآخرون
منشور في: (2025-02-01)

Editorial: Endo- and transcytotic pathways at the brain barriers
حسب: Michelle A. Erickson, وآخرون
منشور في: (2024-05-01)

The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use
حسب: Rita Tavarozzi, وآخرون
منشور في: (2022-02-01)

Engineering multi-specific antibodies against HIV-1
حسب: Neal N. Padte, وآخرون
منشور في: (2018-08-01)

Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1
حسب: Junpeng Qi, وآخرون
منشور في: (2019-08-01)

Developability considerations for bispecific and multispecific antibodies
حسب: Alaa Amash, وآخرون
منشور في: (2024-12-01)

Rapid Generation of Murine Bispecific Antibodies Using FAST-Ig<sup>TM</sup> for Preclinical Screening of HER2/CD3 T-Cell Engagers
حسب: Hikaru Koga, وآخرون
منشور في: (2024-01-01)